4737: Bionime Corporation - Summary | Jitta

Bionime Corporation

TWN:4737

Price
NT$59.80
Loss Chance
54.1%
2.02JITTA SCORE
> 1,000%Over Jitta Line
Jitta Ranking
799 / 1,077
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (9)
Recent Business Performance (22)
Financial Strength (41)
Return to Shareholders (4)
Competitive Advantage (33)
Jitta Signs
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 298.67% in the last quarter (yoy)
CapExVery High
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
2.02
> 1,000%
3.79
641.45%
Health Care Equipment
5.21
155.17%
5.25
64.42%
4.12
76.74%
COMPANY DESCRIPTION
Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offers blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems. It is also involved in the provision of biotechnology services; drug testing; examination of pharmaceutical products; and the sale of precision instruments. Bionime Corporation was incorporated in 2003 and is based in Taichung, Taiwan.